Am J Perinatol 2011; 28(3): 247-252
DOI: 10.1055/s-0030-1268706
© Thieme Medical Publishers

Maternal Periodontal Disease is Associated with Oxidative Stress during Pregnancy

M. Ashley Hickman1 , Kim A. Boggess1 , Kevin L. Moss2 , James D. Beck2 , Steven Offenbacher2
  • 1University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • 2University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill, North Carolina
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. November 2010 (online)

ABSTRACT

We sought to determine if maternal periodontal disease is associated with oxidative stress as measured by serum 8-isoprostane. A secondary analysis was conducted using prospective data from the Oral Conditions and Pregnancy Study. Healthy women enrolled at < 26 weeks' gestational age underwent oral examination and serum sampling. Maternal periodontal disease status was categorized as healthy, mild, or moderate to severe by clinical criteria. Maternal serum was analyzed for 8-isoprostane using ultrasensitive enzyme-linked immunosorbent assay. Elevated 8-isoprostane level was defined as ≥ 75th percentile. Maternal factors associated with elevated 8-isoprostane were determined using chi-square or t test. Multivariable logistic regression was used to assess association between elevated 8-isoprostane and maternal factors. Seven hundred ninety-one women had complete data. Median (interquartile) 8-isoprostane serum level was 1806 (16 to 81,870) pg/dL. Using bivariate analysis, maternal age, race, marital status, utilization of public assistance, and mild or moderate to severe periodontal disease were associated with elevated serum 8-isoprostane. Using logistic regression, moderate to severe periodontal disease (adjusted odds ratio 2.9, 95% confidence interval: 1.7 to 5.0) remained significantly associated with an elevated serum 8-isoprostane level. Maternal periodontal disease is associated with oxidative stress during pregnancy. Further study is needed to determine the role of maternal oxidative stress in periodontal disease-associated adverse pregnancy outcomes.

REFERENCES

  • 1 Chapple I L. Reactive oxygen species and antioxidants in inflammatory diseases.  J Clin Periodontol. 1997;  24 287-296
  • 2 Milne G L, Yin H, Brooks J D, Sanchez S, Jackson Roberts II L, Morrow J D. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.  Methods Enzymol. 2007;  433 113-126
  • 3 Borges Jr I, Moreira E A, Filho D W, de Oliveira T B, da Silva M B, Fröde T S. Proinflammatory and oxidative stress markers in patients with periodontal disease.  Mediators Inflamm. 2007;  2007 45794
  • 4 Panjamurthy K, Manoharan S, Ramachandran C R. Lipid peroxidation and antioxidant status in patients with periodontitis.  Cell Mol Biol Lett. 2005;  10 255-264
  • 5 Chapple I L, Matthews J B. The role of reactive oxygen and antioxidant species in periodontal tissue destruction.  Periodontol 2000. 2007;  43 160-232
  • 6 Boggess K A, Lieff S, Murtha A P, Moss K, Beck J, Offenbacher S. Maternal periodontal disease is associated with an increased risk for preeclampsia.  Obstet Gynecol. 2003;  101 227-231
  • 7 Uotila J, Tuimala R, Pyykkö K, Ahotupa M. Pregnancy-induced hypertension is associated with changes in maternal and umbilical blood antioxidants.  Gynecol Obstet Invest. 1993;  36 153-157
  • 8 Hubel C A. Oxidative stress in the pathogenesis of preeclampsia.  Proc Soc Exp Biol Med. 1999;  222 222-235
  • 9 Chappell L C, Seed P T, Briley A et al.. A longitudinal study of biochemical variables in women at risk of preeclampsia.  Am J Obstet Gynecol. 2002;  187 127-136
  • 10 Wikström A K, Nash P, Eriksson U J, Olovsson M H. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.  Am J Obstet Gynecol. 2009;  201 597 e1-e8
  • 11 Lieff S, Boggess K A, Murtha A P et al.. The oral conditions and pregnancy study: periodontal status of a cohort of pregnant women.  J Periodontol. 2004;  75 116-126
  • 12 Morrow J D, Harris T M, Roberts II L J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids.  Anal Biochem. 1990;  184 1-10
  • 13 Montuschi P, Barnes P J, Roberts II L J. Isoprostanes: markers and mediators of oxidative stress.  FASEB J. 2004;  18 1791-1800
  • 14 Xiong X, Buekens P, Fraser W D, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review.  BJOG. 2006;  113 135-143
  • 15 Shub A, Swain J R, Newnham J P. Periodontal disease and adverse pregnancy outcomes.  J Matern Fetal Neonatal Med. 2006;  19 521-528
  • 16 Siqueira F M, Cota L O, Costa J E, Haddad J P, Lana A M, Costa F O. Maternal periodontitis as a potential risk variable for preeclampsia: a case-control study.  J Periodontol. 2008;  79 207-215
  • 17 Shub A, Wong C, Jennings B, Swain J R, Newnham J P. Maternal periodontal disease and perinatal mortality.  Aust N Z J Obstet Gynaecol. 2009;  49 130-136
  • 18 Srinivas S K, Sammel M D, Stamilio D M et al.. Periodontal disease and adverse pregnancy outcomes: is there an association?.  Am J Obstet Gynecol. 2009;  200 497 e1-e8
  • 19 Manau C, Echeverria A, Agueda A, Guerrero A, Echeverria J J. Periodontal disease definition may determine the association between periodontitis and pregnancy outcomes.  J Clin Periodontol. 2008;  35 385-397
  • 20 Horton A L, Boggess K A, Moss K L, Jared H L, Beck J, Offenbacher S. Periodontal disease early in pregnancy is associated with maternal systemic inflammation among African American women.  J Periodontol. 2008;  79 1127-1132
  • 21 Ruma M, Boggess K, Moss K et al.. Maternal periodontal disease, systemic inflammation, and risk for preeclampsia.  Am J Obstet Gynecol. 2008;  198 389 e1-e5
  • 22 Barden A, Beilin L J, Ritchie J, Croft K D, Walters B N, Michael C A. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy.  Clin Sci (Lond). 1996;  91 711-718
  • 23 Offenbacher S, Beck J D, Jared H L Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR) Investigators et al. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial.  Obstet Gynecol. 2009;  114 551-559
  • 24 Macones G A, Parry S, Nelson D B et al.. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS).  Am J Obstet Gynecol. 2010;  202 147 e1-e8
  • 25 Gilbert G H, Duncan R P, Shelton B J. Social determinants of tooth loss.  Health Serv Res. 2003;  38 (6 Pt 2) 1843-1862
  • 26 Christensen L B, Petersen P E, Steding-Jessen M. Consumption of dental services among adults in Denmark 1994-2003.  Eur J Oral Sci. 2007;  115 174-179
  • 27 Wamala S, Merlo J, Boström G. Inequity in access to dental care services explains current socioeconomic disparities in oral health: the Swedish National Surveys of Public Health 2004-2005.  J Epidemiol Community Health. 2006;  60 1027-1033

M. Ashley HickmanM.D. 

Fellow and Clinical Instructor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology

University of North Carolina School of Medicine, Chapel Hill, 3010 Old Clinic Bldg. CB #7516, Chapel Hill, NC 27599-7516

eMail: m.ashley.hickman@gmail.com